Related Content
Search Google Scholar for:
More Information
Related Jobs from ScienceCareers
|
Originally published in Science Express on 19 December 2002
Science 17 January 2003: Vol. 299. no. 5605, pp. 411 - 414
DOI: 10.1126/science.1078942
|
|
Reports
Production of 1,3-Galactosyltransferase-Deficient Pigs
Carol J. Phelps,1
Chihiro Koike,34
Todd D. Vaught,1
Jeremy Boone,1
Kevin D. Wells,1
Shu-Hung Chen,1
Suyapa Ball,1
Susan M. Specht,34
Irina A. Polejaeva,1
Jeff A. Monahan,1
Pete M. Jobst,1
Sugandha B. Sharma,34
Ashley E. Lamborn,1
Amy S. Garst,1
Marilyn Moore,2
Anthony J. Demetris,35
William A. Rudert,36
Rita Bottino,36
Suzanne Bertera,36
Massimo Trucco,36
Thomas E. Starzl,34
Yifan Dai,1*
David L. Ayares1*
The enzyme 1,3-galactosyltransferase ( 1,3GT or GGTA1)
synthesizes 1,3-galactose ( 1,3Gal) epitopes
(Gal 1,3Gal 1,4GlcNAc-R), which are the major xenoantigens causing
hyperacute rejection in pig-to-human xenotransplantation. Complete
removal of 1,3Gal from pig organs is the critical step toward the
success of xenotransplantation. We reported earlier the targeted
disruption of one allele of the 1,3GT gene in cloned pigs. A
selection procedure based on a bacterial toxin was used to select for
cells in which the second allele of the gene was knocked out.
Sequencing analysis demonstrated that knockout of the second allele of
the 1,3GT gene was caused by a T-to-G single point mutation at the
second base of exon 9, which resulted in inactivation of the 1,3GT
protein. Four healthy 1,3GT double-knockout female piglets were
produced by three consecutive rounds of cloning. The piglets carrying a
point mutation in the 1,3GT gene hold significant value, as they
would allow production of 1,3Gal-deficient pigs free of
antibiotic-resistance genes and thus have the potential to make a safer
product for human use.
1 PPL Therapeutics Inc., 1700 Kraft Drive,
Blacksburg, VA 24060, USA.
2 PPL Therapeutics Ltd.,
Roslin, Midlothian, EH25 9PP, UK.
3 Thomas E. Starzl
Transplantation Institute,
4 Department of Surgery,
5 Department of Pathology, and
6 Department of Pediatrics (Division of
Immunogenetics) of University of Pittsburgh Medical Center (UPMC) and
Children's Hospital, Pittsburgh, PA 15213, USA.
*
To whom correspondence should be addressed.
E-mail: ydai{at}ppl-therapeutics.com;
dayares{at}ppl-therapeutics.com
Read the Full Text
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Cytokine Secretion Depends on Gal{alpha}(1,3)Gal Expression in a Pig-to-Human Whole Blood Model.
- M. Saethre, M. K. J. Schneider, J. D. Lambris, P. Magotti, G. Haraldsen, J. D. Seebach, and T. E. Mollnes (2008)
J. Immunol.
180, 6346-6353
| Abstract »
| Full Text »
| PDF »
- Identification of Amino Acid Positions Involved in HLA-E Expression.
- K. Matsunami, E. Okura, H. Uchida, H. Otsuka, M. Fukuzawa, and S. Miyagawa (2008)
J. Biochem.
143, 641-647
| Abstract »
| Full Text »
| PDF »
- Rapidly induced, T-cell independent xenoantibody production is mediated by marginal zone B cells and requires help from NK cells.
- S. Li, Y. Yan, Y. Lin, D. M. Bullens, O. Rutgeerts, J. Goebels, C. Segers, L. Boon, A. Kasran, R. De Vos, et al. (2007)
Blood
110, 3926-3935
| Abstract »
| Full Text »
| PDF »
- Role for CD47-SIRP{alpha} signaling in xenograft rejection by macrophages.
- K. Ide, H. Wang, H. Tahara, J. Liu, X. Wang, T. Asahara, M. Sykes, Y.-G. Yang, and H. Ohdan (2007)
PNAS
104, 5062-5066
| Abstract »
| Full Text »
| PDF »
- Functionally important glycosyltransferase gain and loss during catarrhine primate emergence.
- C. Koike, M. Uddin, D. E. Wildman, E. A. Gray, M. Trucco, T. E. Starzl, and M. Goodman (2007)
PNAS
104, 559-564
| Abstract »
| Full Text »
| PDF »
- Reduction of hyperacute rejection and protection of metabolism and function in hearts of human decay accelerating factor (hDAF)-expressing pigs.
- R. T. Smolenski, M. Forni, M. Maccherini, M. L. Bacci, E. M. Slominska, H. Wang, P. Fornasari, R. Giovannoni, F. Simeone, A. Zannoni, et al. (2007)
Cardiovasc Res
73, 143-152
| Abstract »
| Full Text »
| PDF »
- Cloned Transgenic Swine Via In Vitro Production and Cryopreservation.
- R. Li, L. Lai, D. Wax, Y. Hao, C. N. Murphy, A. Rieke, M. Samuel, M. L. Linville, S. W. Korte, R. W. Evans, et al. (2006)
Biol Reprod
75, 226-230
| Abstract »
| Full Text »
| PDF »
- Xenograft rejection--all that glitters is not Gal.
- B. Sprangers, M. Waer, and A. D. Billiau (2006)
Nephrol. Dial. Transplant.
21, 1486-1488
| Full Text »
| PDF »
- The Molecular Basis for Gal{alpha}(1,3)Gal Expression in Animals with a Deletion of the {alpha}1,3Galactosyltransferase Gene.
- J. Milland, D. Christiansen, B. D. Lazarus, S. G. Taylor, P. X. Xing, and M. S. Sandrin (2006)
J. Immunol.
176, 2448-2454
| Abstract »
| Full Text »
| PDF »
- Multifaceted Therapeutic Approaches for a Multigenic Disease.
- R. Bottino and M. Trucco (2005)
Diabetes
54, S79-S86
| Abstract »
| Full Text »
| PDF »
- Thrombotic Microangiopathic Glomerulopathy in Human Decay Accelerating Factor-Transgenic Swine-to-Baboon Kidney Xenografts.
- A. Shimizu, K. Yamada, S. Yamamoto, J. M. Lavelle, R. N. Barth, S. C. Robson, D. H. Sachs, and R. B. Colvin (2005)
J. Am. Soc. Nephrol.
16, 2732-2745
| Abstract »
| Full Text »
| PDF »
- Targeted Deletion of Fgl-2/Fibroleukin in the Donor Modulates Immunologic Response and Acute Vascular Rejection in Cardiac Xenografts.
- M. Mendicino, M. Liu, A. Ghanekar, W. He, C. Koscik, I. Shalev, M. Javadi, J. Turnbull, W. Chen, L. Fung, et al. (2005)
Circulation
112, 248-256
| Abstract »
| Full Text »
| PDF »
- Patient-Specific Embryonic Stem Cells Derived from Human SCNT Blastocysts.
- W. S. Hwang, S. I. Roh, B. C. Lee, S. K. Kang, D. K. Kwon, S. Kim, S. J. Kim, S. W. Park, H. S. Kwon, C. K. Lee, et al. (2005)
Science
308, 1777-1783
| Abstract »
| Full Text »
| PDF »
- Monocyte Adhesion to Xenogeneic Endothelium during Laminar Flow Is Dependent on {alpha}-Gal-Mediated Monocyte Activation.
- M. D. Peterson, R. Jin, S. Hyduk, P. Duchesneau, M. I. Cybulsky, and T. K. Waddell (2005)
J. Immunol.
174, 8072-8081
| Abstract »
| Full Text »
| PDF »
- Prevention of PERV Infections in Pig to Human Xenotransplantation by the RNA Interference Silences Gene.
- S. Miyagawa, S. Nakatsu, T. Nakagawa, A. Kondo, K. Matsunami, K. Hazama, J. Yamada, K. Tomonaga, T. Miyazawa, and R. Shirakura (2005)
J. Biochem.
137, 503-508
| Abstract »
| Full Text »
| PDF »
- Chimerism and tolerance in transplantation.
- T. E. Starzl (2004)
PNAS
101, 14607-14614
| Abstract »
| Full Text »
| PDF »
- Delta-Short Consensus Repeat 4-Decay Accelerating Factor (DAF: CD55) Inhibits Complement-Mediated Cytolysis but Not NK Cell-Mediated Cytolysis.
- S. Miyagawa, T. Kubo, K. Matsunami, T. Kusama, K. Beppu, H. Nozaki, T. Moritan, C. Ahn, J. Y. Kim, D. Fukuta, et al. (2004)
J. Immunol.
173, 3945-3952
| Abstract »
| Full Text »
| PDF »
- Role of Messenger RNA Expression of Platelet Activating Factor and Its Receptor in Porcine In Vitro-Fertilized and Cloned Embryo Development.
- S. H. Lee, D. Y. Kim, D. H. Nam, S. H. Hyun, G. S. Lee, H. S. Kim, C.-K. Lee, S. K. Kang, B. C. Lee, and W. S. Hwang (2004)
Biol Reprod
71, 919-925
| Abstract »
| Full Text »
| PDF »
- Porcine Endogenous Retrovirus Transmission Characteristics of Galactose {alpha}1-3 Galactose-Deficient Pig Cells.
- G. Quinn, J. C. Wood, D. J. J. Ryan, K. M. Suling, K. M. Moran, D. L. Kolber-Simonds, J. L. Greenstein, H.-J. Schuurman, R. J. Hawley, and C. Patience (2004)
J. Virol.
78, 5805-5811
| Abstract »
| Full Text »
| PDF »
- Reduced Sensitivity to Human Serum Inactivation of Enveloped Viruses Produced by Pig Cells Transgenic for Human CD55 or Deficient for the Galactosyl-{alpha}(1-3) Galactosyl Epitope.
- S. Magre, Y. Takeuchi, G. Langford, A. Richards, C. Patience, and R. Weiss (2004)
J. Virol.
78, 5812-5819
| Abstract »
| Full Text »
| PDF »
- Susceptibility of porcine cytomegalovirus to antiviral drugs.
- J. F. L. Fryer, P. D. Griffiths, V. C. Emery, and D. A. Clark (2004)
J. Antimicrob. Chemother.
53, 975-980
| Abstract »
| Full Text »
| PDF »
- Lack of Galactose-{alpha}-1,3-Galactose Expression on Porcine Endothelial Cells Prevents Complement-Induced Lysis but Not Direct Xenogeneic NK Cytotoxicity.
- B. C. Baumann, P. Forte, R. J. Hawley, R. Rieben, M. K. J. Schneider, and J. D. Seebach (2004)
J. Immunol.
172, 6460-6467
| Abstract »
| Full Text »
| PDF »
- Transgenic pigs expressing plant genes.
- H. Niemann (2004)
PNAS
101, 7211-7212
| Full Text »
| PDF »
- Production of {alpha}-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations.
- D. Kolber-Simonds, L. Lai, S. R. Watt, M. Denaro, S. Arn, M. L. Augenstein, J. Betthauser, D. B. Carter, J. L. Greenstein, Y. Hao, et al. (2004)
PNAS
101, 7335-7340
| Abstract »
| Full Text »
| PDF »
- Xenotransplantation and the Future of Renal Replacement.
- M. Cascalho, B. M. Ogle, and J. L. Platt (2004)
J. Am. Soc. Nephrol.
15, 1106-1112
| Full Text »
| PDF »
- Intracellularly Expressed Single-Domain Antibody against p15 Matrix Protein Prevents the Production of Porcine Retroviruses.
- S. Dekker, W. Toussaint, G. Panayotou, T. de Wit, P. Visser, F. Grosveld, and D. Drabek (2003)
J. Virol.
77, 12132-12139
| Abstract »
| Full Text »
| PDF »
- Guidelines for Xenotransplantation.
- M. Sykes, M. Sandrin, A. D'Apice, and the Ethics Committee of the International Xenotran (2003)
N. Engl. J. Med.
349, 1294-1295
| Full Text »
| PDF »
- Production of {alpha}1,3-Galactosyltransferase-Knockout Cloned Pigs Expressing Human {alpha}1,2-Fucosylosyltransferase.
- J. J. Ramsoondar, Z. Machaty, C. Costa, B. L. Williams, W. L. Fodor, and K. R. Bondioli (2003)
Biol Reprod
69, 437-445
| Abstract »
| Full Text »
| PDF »
- .
- (2003)
Vet. Pathol.
40, 343
| Full Text »
| PDF »
|
|